DNA methylation in obesity and type 2 diabetes

Annals of Medicine

Volumn 46, Issue 3, 2014, Pages 103-113

  De Mello, Vanessa Derenji Ferreira ^a   Pulkkinen, Leena ^a   Lalli, Marianne ^a   Kolehmainen, Marjukka ^a   Pihlajamäki, Jussi ^a,b   Uusitupa, Matti ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Diabetes mellitus type 2; DNA methylation; Epigenomics; Obesity

Indexed keywords

AGING; CHROMATIN STRUCTURE; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; HUMAN; HYPERGLYCEMIA; LIFESTYLE MODIFICATION; MOLECULAR MECHANICS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVERNUTRITION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; UTERUS; WEIGHT REDUCTION; FETUS DEVELOPMENT; GENETIC EPIGENESIS; METABOLISM;

DIABETES MELLITUS, TYPE 2; DNA METHYLATION; EPIGENESIS, GENETIC; FETAL DEVELOPMENT; HUMANS; HYPERGLYCEMIA; OBESITY; WEIGHT LOSS;

EID: 84899861900     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2013.857259     Document Type: Review

References (144)

1. McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med.2010; 363: 2339-50.
2. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010; 42: 937-48.
3. Uusitupa MI, Stancakova A, Peltonen M, Eriksson JG, Lindström J, Aunola S, et al. Impact of positive family history and genetic risk variants on the incidence of diabetes: the Finnish Diabetes Prevention Study. Diabetes Care. 2011; 34: 418-23.
4. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346: 393-403.
5. Lindström J, Peltonen M, Eriksson JG, Ilanne-Parikka P, Aunola S, Keinanen-Kiukaanniemi S, et al. Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia. 2013; 56: 284-93.
6. Bouchard L, Rabasa-Lhoret R, Faraj M, Lavoie ME, Mill J, Perusse L, et al. Diff erential epigenomic and transcriptomic responses in subcutaneous adipose tissue between low and high responders to caloric restriction. Am J Clin Nutr. 2010; 91: 309-20.
7. Nitert MD, Dayeh T, Volkov P, Elgzyri T, Hall E, Nilsson E, et al. Impact of an exercise intervention on DNA methylation in skeletal muscle from fi rst-degree relatives of patients with type 2 diabetes. Diabetes. 2012; 61: 3322-32.
8. Rönn T, Volkov P, Davegardh C, Dayeh T, Hall E, Olsson AH, et al. A six months exercise intervention infl uences the genome-wide DNA methylation pattern in human adipose tissue. PLoS Genet. 2013; 9: e1003572.
9. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med. 2008; 359: 61-73.
10. R etinopathy and nephropathy in patients with type 1 diabetes four years aft er a trial of intensive therapy. Th e Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med. 2000; 342: 381-89.
11. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008; 359: 1577-89.
12. Brasacchio D, Okabe J, Tikellis C, Balcerczyk A, George P, Baker EK, et al. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes. 2009; 58: 1229-36.
13. Pirola L, Balcerczyk A, Tothill RW, Haviv I, Kaspi A, Lunke S, et al. Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells. Genome Res. 20; 21: 1601-15.
14. Olsen AS, Sarras MP Jr, Leontovich A, Intine RV. Heritable transmission of diabetic metabolic memory in zebrafi sh correlates with DNA hypomethylation and aberrant gene expression. Diabetes. 2012; 61: 485-91.
15. Yang BT, Dayeh TA, Kirkpatrick CL, Taneera J, Kumar R, Groop L, et al. Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets. Diabetologia. 2011; 54: 360-7.
16. Yang BT, Dayeh TA, Volkov PA, Kirkpatrick CL, Malmgren S, Jing X, et al. Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes. Mol Endocrinol. 2012; 26: 1203-12.
17. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C, et al. Fetal and infant growth and impaired glucose tolerance at age. BMJ. 1991; 303: 1019-22.
18. Hales CN, Barker DJ. The thrifty phenotype hypothesis. B r Med Bull. 2001; 60: 5-20.
19. Kaijser M, Bonamy AK, Akre O, Cnattingius S, Granath F, Norman M, et al. Perinatal risk factors for diabetes in later life. Diabetes. 2009; 58: 523-6.
20. Pilgaard K, Faerch K, Carstensen B, Poulsen P, Pisinger C, Pedersen O, et al. Low birthweight and premature birth are both associated with type 2 diabetes in a random sample of middle-aged Danes. Diabetologia. 2010; 53: 2526-30.
21. Barker DJ. Th e malnourished baby and infant. Br Med Bull. 2001; 60: 69-88.
22. Dabelea D, Knowler WC, Pettitt DJ. Effect of diabetes in pregnancy on off spring: follow-up research in the Pima Indians. J Matern Fetal Med. 2000; 9: 83-8.
23. Dabelea D, Hanson RL, Lindsay RS, Pettitt DJ, Imperatore G, Gabir MM, et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes. 2000; 49: 2208-11.
24. Deierlein AL, Siega-Riz AM, Chantala K, Herring AH. Th e association between maternal glucose concentration and child BMI at age 3 years. Diabetes Care. 2011; 34: 480-4.
25. Ravelli AC, van der Meulen JH, Michels RP, Osmond C, Barker DJ, Hales CN, et al. Glucose tolerance in adults aft er prenatal exposure to famine. Lancet. 1998; 351: 173-7.
26. McCance DR, Pettitt DJ, Hanson RL, Jacobsson LT, Knowler WC, Bennett PH. Birth weight and non-insulin dependent diabetes: thrift y genotype, thrift y phenotype, or surviving small baby genotype? BMJ. 1994; 308: 942-5.
27. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Ascherio AL, Stampfer MJ. Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation. 1996; 94: 3246-50.
28. Crowther NJ, Trusler J, Cameron N, Toman M, Gray IP. Relation between weight gain and beta-cell secretory activity and non-esterifi ed fatty acid production in 7-year-old African children: results from the Birth to Ten study. Diabetologia. 2000; 43: 978-85.
29. Forsen T, Eriksson J, Tuomilehto J, Reunanen A, Osmond C, Barker D. Th e fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med. 2000; 133: 176-82.
30. Norris SA, Osmond C, Gigante D, Kuzawa CW, Ramakrishnan L, Lee NR, et al. Size at birth, weight gain in infancy and childhood, and adult diabetes risk in fi ve low-or middle-income country birth cohorts. Diabetes Care. 2012; 35: 72-9.
31. Hanson M, Godfrey KM, Lillycrop KA, Burdge GC, Gluckman PD. Developmental plasticity and developmental origins of noncommunicable disease: theoretical considerations and epigenetic mechanisms. Prog Biophys Mol Biol. 2011; 106: 272-80.
32. Michels KB, Harris HR, Barault L. Birthweight, maternal weight trajectories and global DNA methylation of LINE-1 repetitive elements. PLoS One. 2011; 6: e25254.
33. Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES, et al. Persistent epigenetic diff erences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci USA. 2008; 105: 17046-9.
34. Ishida M, Moore GE. Th e role of imprinted genes in humans. Mol Aspects Med. 2013; 34: 826-40.
35. Tobi EW, Lumey LH, Talens RP, Kremer D, Putter H, Stein AD, et al. DNA methylation diff erences aft er exposure to prenatal famine are common and timing-and sex-specifi c. Hum Mol Genet. 2009; 18: 4046-53.
36. Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science. 2001; 293: 1089-93.
37. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003; 33(Suppl): 245-54.
38. Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A. An operational defi nition of epigenetics. Genes Dev. 2009; 23: 781-3.
39. Pollin TI. Epigenetics and diabetes risk: not just for imprinting anymore? Diabetes. 2011; 60: 1859-60.
40. Tammen S A, Friso S, Choi S W. Epigenetics: the link between nature and nurture. Mol Aspects Med. 2013; 34: 753-64.
41. Hirst M, Marra MA. Epigenetics and human disease. Int J Biochem Cell Biol. 2009; 41: 136-46.
42. Stead LM, Brosnan JT, Brosnan ME, Vance DE, Jacobs RL. Is it time to reevaluate methyl balance in humans? Am J Clin Nutr. 2006; 83: 5-10.
43. Ross SA. Diet and DNA methylation interactions in cancer prevention. Ann N Y Acad Sci. 2003; 983: 197-207.
44. Li E, Beard C, Jaenisch R. Role for DNA methylation in genomic imprinting. Nature. 1993; 366: 362-5.
45. Hansen RS, Stoger R, Wijmenga C, Stanek AM, Canfield TK, Luo P, et al. Escape from gene silencing in ICF syndrome: evidence for advanced replication time as a major determinant. Hum Mol Genet. 2000; 9: 2575-87.
46. Waterland RA, Jirtle RL. Transposable elements: targets for early nutritional Effects on epigenetic gene regulation. Mol Cell Biol. 2003; 23: 5293-300.
47. Daniels R, Lowell S, Bolton V, Monk M. Transcription of tissue-specifi c genes in human preimplantation embryos. Hum Reprod. 1997; 12: 2251-6.
48. Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999; 99: 247-57.
49. Ollikainen M, Smith KR, Joo EJ, Ng HK, Andronikos R, Novakovic B, et al. DNA methylation analysis of multiple tissues from newborn twins reveals both genetic and intrauterine components to variation in the human neonatal epigenome. Hum Mol Genet. 2010; 19: 4176-88.
50. Denis H, Ndlovu M N, Fuks F. Regulation of mammalian DNA methyltransferases: a route to new mechanisms. EMBO Rep. 2011; 12: 647-56.
51. Jia D, Jurkowska RZ, Zhang X, Jeltsch A, Cheng X. Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation. Nature. 2007; 449: 248-51.
52. Rougier N, Bourc'his D, Gomes DM, Niveleau A, Plachot M, Paldi A, et al. Chromosome methylation patterns during mammalian preimplantation development. Genes Dev. 1998; 12: 2108-13.
53. He YF, Li BZ, Li Z, Liu P, Wang Y, Tang Q, et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science. 2011; 333: 1303-7.
54. Shen L, Wu H, Diep D, Yamaguchi S, D'Alessio AC, Fung HL, et al. Genome-wide analysis reveals TET-and TDG-dependent 5-methylcytosine oxidation dynamics. Cell. 2013; 153: 692-706.
55. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science. 2009; 324: 930-935.
56. Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science. 2011; 333: 1300-3.
57. Inoue A, Shen L, Dai Q, He C, Zhang Y. Generation and replicationdependent dilution of 5fC and 5caC during mouse preimplantation development. Cell Res. 2011; 21: 1670-6.
58. Kellinger MW, Song CX, Chong J, Lu XY, He C, Wang D. 5-formylcytosine and 5-carboxylcytosine reduce the rate and substrate specifi city of RNA polymerase II transcription. Nat Struct Mol Biol. 2012; 19: 831-3.
59. Cooper D N, Krawczak M. Cytosine methylation and the fate of CpG dinucleotides in vertebrate genomes. Hum Genet. 1989; 83: 181-8.
60. Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature. 2008; 454: 766-70.
61. Lister R, Pelizzola M, Dowen R H, Hawkins R D, Hon G, Tonti-Filippini J, et al. Human DNA methylomes at base resolution show widespread epigenomic diff erences. Nature. 2009; 462: 315-22.
62. Feng S, Cokus SJ, Zhang X, Chen PY, Bostick M, Goll MG, et al. Conservation and divergence of methylation patterning in plants and animals. Proc Natl Acad Sci USA. 2010; 107: 8689-94.
63. Su J, Yan H, Wei Y, Liu H, Liu H, Wang F, et al. CpGMPs: identifi cation of CpG methylation patterns of genomic regions from high-throughput bisulfi te sequencing data. Nucleic Acids Res. 2013; 41: e4.
64. Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D'Souza C, Fouse SD, et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature. 2010; 466: 253-7.
65. Hodges E, Molaro A, Dos Santos CO, Thekkat P, Song Q, Uren PJ, et al. Directional DNA methylation changes and complex intermediate states accompany lineage specifi city in the adult hematopoietic compartment. Mol Cell. 2011; 44: 17-28.
66. Schmidl C, Klug M, Boeld TJ, Andreesen R, Hoffmann P, Edinger M, et al. Lineage-specifi c DNA methylation in T cells correlates with histone methylation and enhancer activity. Genome Res. 2009; 19: 1165-74.
67. Cedar H, Bergman Y. Linking DNA methylation and histone modifi cation: patterns and paradigms. Nat Rev Genet. 2009; 10: 295-304.
68. Suzuki MM, Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet. 2008; 9: 465-76.
69. Bird AP, Wolffe AP. Methylation-induced repression-belts, braces, and chromatin. Cell. 1999; 99: 451-4.
70. Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M, et al. DNA methylation profi ling of human chromosomes 6, 20 and 22. Nat Genet. 2006; 38: 1378-85.
71. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, et al. Th e human colon cancer methylome shows similar hypo-and hypermethylation at conserved tissue-specifi c CpG island shores. Nat Genet. 2009; 41: 178-86.
72. Nagae G, Isagawa T, Shiraki N, Fujita T, Yamamoto S, Tsutsumi S, et al. Tissue-specifi c demethylation in CpG-poor promoters during cellular diff erentiation. Hum Mol Genet. 2011; 20: 2710-21.
73. Lande-Diner L, Zhang J, Ben-Porath I, Amariglio N, Keshet I, Hecht M, et al. Role of DNA methylation in stable gene repression. J Biol Chem. 2007; 282: 12194-200.
74. Fuks F, Hurd PJ, Wolf D, Nan X, Bird AP, Kouzarides T. Th e methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem. 2003; 278: 4035-40.
75. Tazi J, Bird A. Alternative chromatin structure at CpG islands. Cell. 1990; 60: 909-20.
76. Agalioti T, Lomvardas S, Parekh B, Yie J, Maniatis T, Thanos D. Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter. Cell. 2000; 103: 667-78.
77. McEwen KR, Ferguson-Smith AC. Distinguishing epigenetic marks of developmental and imprinting regulation. Epigenetics Chromatin. 2010; 3:2.
78. Fuks F, Burgers WA, Godin N, Kasai M, Kouzarides T. Dnmt3a binds deacetylases and is recruited by a sequence-specifi c repressor to silence transcription. EMBO J. 2001; 20: 2536-44.
79. Bachman KE, Rountree MR, Baylin SB. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J Biol Chem. 2001; 276: 32282-7.
80. Feldman N, Gerson A, Fang J, Li E, Zhang Y, Shinkai Y, et al. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat Cell Biol. 2006; 8: 188-94.
81. Epsztejn-Litman S, Feldman N, Abu-Remaileh M, Shufaro Y, Gerson A, Ueda J, et al. De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nat Struct Mol Biol. 2008; 15: 1176-83.
82. Coolen MW, Statham AL, Qu W, Campbell MJ, Henders AK, Montgomery GW, et al. Impact of the genome on the epigenome is manifested in DNA methylation patterns of imprinted regions in monozygotic and dizygotic twins. PLoS One. 2011; 6: e25590.
83. Tobi EW, Slagboom PE, van Dongen J, Kremer D, Stein AD, Putter H, et al. Prenatal famine and genetic variation are independently and additively associated with DNA methylation at regulatory loci within IGF2/H19. PLoS One. 2012; 7: e37933.
84. Gutierrez-Arcelus M, Lappalainen T, Montgomery SB, Buil A, Ongen H, Yurovsky A, et al. Passive and active DNA methylation and the interplay with genetic variation in gene regulation. Elife. 2013; 2: e00523.
85. Ling C, Poulsen P, Simonsson S, Rönn T, Holmkvist J, Almgren P, et al. Genetic and epigenetic factors are associated with expression of respiratory chain component NDUFB6 in human skeletal muscle. J Clin Invest. 2007; 117: 3427-35.
86. Ronn T, Poulsen P, Hansson O, Holmkvist J, Almgren P, Nilsson P, et al. Age infl uences DNA methylation and gene expression of COX7A1 in human skeletal muscle. Diabetologia. 2008; 51: 1159-68.
87. Laird P W. Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet. 2010; 11: 191-203.
88. Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E, et al. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res. 2005; 33: 6823-36.
89. Mansego ML, Milagro FI, Campion J, Martinez JA. Techniques of DNA methylation analysis with nutritional applications. J Nutrigenet Nutrigenomics. 2013; 6: 83-96.
90. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell. 2001; 104: 531-43.
91. Engström G, Hedblad B, Stavenow L, Lind P, Janzon L, Lindgarde F. Infl ammation-sensitive plasma proteins are associated with future weight gain. Diabetes. 2003; 52: 2097-101.
92. Festa A, D'Agostino R Jr, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, et al. Th e relation of body fat mass and distribution to markers of chronic infl ammation. Int J Obes Relat Metab Disord. 2001; 25: 1407-15.
93. Wellen KE, Hotamisligil GS. Infl ammation, stress, and diabetes. J Clin Invest. 2005; 115: 1111-9.
94. Patel PS, Buras ED, Balasubramanyam A. Th e role of the immune system in obesity and insulin resistance. J Obes. 2013; 2013: 616193.
95. Eeg-Olofsson K, Cederholm J, Nilsson PM, Zethelius B, Nunez L, Gudbjornsdottir S, et al. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients. Diabetologia. 2009; 52: 65-73.
96. Prospective Studies Collaboration, Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, et al. Body-mass index and causespecifi c mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009; 373: 1083-96.
97. National Institutes of Health, National Heart, Lung and Blood Institute . The Practical guide: identifi cation, evaluation, and treatment of overweight and obesity in adults. NIH Publication No. 00-4084. Bethesda, Maryland: National Institutes of Health; 2000.
98. Wardle J, Carnell S, Haworth CM, Farooqi IS, O'Rahilly S, Plomin R. Obesity associated genetic variation in FTO is associated with diminished satiety. J Clin Endocrinol Metab. 2008; 93: 3640-3.
99. Speakman JR, Rance KA, Johnstone AM. Polymorphisms of the FTO gene are associated with variation in energy intake, but not energy expenditure. Obesity (Silver Spring). 2008; 16: 1961-5.
100. Kilpelainen TO, Qi L, Brage S, Sharp SJ, Sonestedt E, DemeraThe, et al. Physical activity attenuates the infl uence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med. 2011; 8: e1001116.
101. Sonestedt E, Roos C, Gullberg B, Ericson U, Wirfalt E, Orho-Melander M. Fat and carbohydrate intake modify the association between genetic variation in the FTO genotype and obesity. Am J Clin Nutr. 2009; 90: 1418-25.
102. Relton CL, Groom A, St Pourcain B, Sayers AE, Swan DC, Embleton ND, et al. DNA methylation patterns in cord blood DNA and body size in childhood. PLoS One. 2012; 7: e31821.
103. Perkins E, Murphy SK, Murtha AP, Schildkraut J, Jirtle RL, Demark-Wahnefried W, et al. Insulin-like growth factor 2/H19 methylation at birth and risk of overweight and obesity in children. J Pediatr. 2012; 161: 31-9.
104. Murphy SK, Huang Z, Wen Y, Spillman MA, Whitaker RS, Simel LR, et al. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer. Mol Cancer Res. 2006; 4: 283-92.
105. Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, Brandenburg S, et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science. 2003; 299: 1753-5.
106. Perng W, Mora-Plazas M, Marin C, Rozek L S, Baylin A, Villamor E. A prospective study of LINE-1DNA methylation and development of adiposity in school-age children. PLoS One. 2013; 8: e62587.
107. Kuehnen P, Mischke M, Wiegand S, Sers C, Horsthemke B, Lau S, et al. An Alu element-associated hypermethylation variant of the POMC gene is associated with childhood obesity. PLoS Genet. 2012; 8: e1002543.
108. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A. Severe early-onset obesity, adrenal insuffi ciency and red hair pigmentation caused by POMC mutations in humans. Nat Genet. 1998; 19: 155-7.
109. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 1997; 385: 165-8.
110. Godfrey KM, Sheppard A, Gluckman PD, Lillycrop KA, Burdge GC, McLean C, et al. Epigenetic gene promoter methylation at birth is associated with child's later adiposity. Diabetes. 2011; 60: 1528-34.
111. Wang X, Zhu H, Snieder H, Su S, Munn D, Harshfield G, et al. Obesity related methylation changes in DNA of peripheral blood leukocytes. BMC Med. 2010; 887.
112. Zhao J, Goldberg J, Vaccarino V. Promoter methylation of serotonin transporter gene is associated with obesity measures: a monozygotic twin study. Int J Obes (Lond). 2013; 37: 140-5.
113. King BM. The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight. Physiol Behav. 2006; 87: 221-44.
114. Sookoian S, Gianotti TF, Gemma C, Burgueno A, Pirola CJ. Contribution of the functional 5-HTTLPR variant of the SLC6A4 gene to obesity risk in male adults. Obesity (Silver Spring). 2008; 16: 488-91.
115. Lan MY, Chang YY, Chen WH, Kao YF, Lin HS, Liu JS. Serotonin transporter gene promoter polymorphism is associated with body mass index and obesity in non-elderly stroke patients. J Endocrinol Invest. 2009; 32: 119-22.
116. Milagro FI, Campion J, Cordero P, Goyenechea E, Gomez-Uriz AM, Abete I, et al. A dual epigenomic approach for the search of obesity biomarkers: DNA methylation in relation to diet-induced weight loss. FASEB J. 2011; 25: 1378-89.
117. Moleres A, Campion J, Milagro FI, Marcos A, Campoy C, Garagorri JM, et al. Diff erential DNA methylation patterns between high and low responders to a weight loss intervention in overweight or obese adolescents: the EVASYON study. FASEB J. 2013; 27: 2504-12.
118. Campion J, Milagro FI, Goyenechea E, Martinez JA. TNF-alpha promoter methylation as a predictive biomarker for weight-loss response. Obesity (Silver Spring). 2009; 17: 1293-7.
119. Cordero P, Campion J, Milagro FI, Goyenechea E, Steemburgo T, Javierre BM, et al. Leptin and TNF-alpha promoter methylation levels measured by MSP could predict the response to a low-calorie diet. J Physiol Biochem. 2011; 67: 463-70.
120. Milagro FI, Gomez-Abellan P, Campion J, Martinez JA, Ordovas JM, Garaulet M. CLOCK, PER2 and BMAL1 DNA methylation: association with obesity and metabolic syndrome characteristics and monounsaturated fat intake. Chronobiol Int. 2012; 29: 1180-94.
121. Barres R, Kirchner H, Rasmussen M, Yan J, Kantor FR, Krook A, et al. Weight loss aft er gastric bypass surgery in human obesity remodels promoter methylation. Cell Rep. 2013; 3: 1020-7.
122. Fischbach BV, Trout KL, Lewis J, Luis CA, Sika M. WAGR syndrome: a clinical review of 54 cases. Pediatrics. 2005; 116: 984-8.
123. Steege A, Fahling M, Paliege A, Bondke A, Kirschner KM, Martinka P, et al. Wilms ' tumor protein (-KTS) modulates renin gene transcription. Kidney Int. 2008; 74: 458-66.
124. Kim JH, Shin HD, Park BL, Cho YM, Kim SY, Lee HK, et al. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha promoter polymorphisms are associated wiThearly-onset type 2 diabetes mellitus in the Korean population. Diabetologia. 2005; 48: 1323-30.
125. Lai CQ, Tucker KL, Parnell LD, Adiconis X, Garcia-Bailo 125. B, Griffith J, et al. PPARGC1A variation associated with DNA damage, diabetes, and cardiovascular diseases: the Boston Puerto Rican Health Study. Diabetes. 2008; 57: 809-16.
126. Jeoung NH, Harris RA. Pyruvate dehydrogenase kinase-4 defi ciency lowers blood glucose and improves glucose tolerance in diet-induced obese mice. Am J Physiol Endocrinol Metab. 2008; 295: E46-54.
127. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010; 42: 105-16.
128. Brøns C, Jacobsen S, Nilsson E, Rönn T, Jensen CB, Storgaard H, et al. Deoxyribonucleic acid methylation and gene expression of PPARGC1A in human muscle is infl uenced by high-fat overfeeding in a birth-weightdependent manner. J Clin Endocrinol Metab. 2010; 95: 3048-56.
129. Jacobsen SC, Brøns C, Bork-Jensen J, Ribel-Madsen R, Yang B, Lara E, et al. Effects of short-term high-fat overfeeding on genome-wide DNA methylation in the skeletal muscle of healthy young men. Diabetologia. 2012; 55: 3341-9.
130. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011; 94: 311-21.
131. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005; 54: 1615-25.
132. Wang J, Kuusisto J, Vanttinen M, Kuulasmaa T, Lindström J, Tuomilehto J, et al. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion. Diabetologia. 2007; 50: 1192-200.
133. Kilpelainen TO, Lakka TA, Laaksonen DE, Lindström J, Eriksson JG, Valle TT, et al. SNPs in PPARG associate with type 2 diabetes and interact with physical activity. Med Sci Sports Exerc. 2008; 40: 25-33.
134. Haupt A, Thamer C, Heni M, Ketterer C, Machann J, Schick F, et al. Gene variants of TCF7L2 infl uence weight loss and body composition during lifestyle intervention in a population at risk for type 2 diabetes. Diabetes. 2010; 59: 747-50.
135. Zhao J, Goldberg J, Bremner JD, Vaccarino V. Global DNA methylation is associated with insulin resistance: a monozygotic twin study. Diabetes. 2012; 61: 542-6.
136. Barres R, Osler ME, Yan J, Rune A, Fritz T, Caidahl K, et al. Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab. 2009; 10: 189-98.
137. Ling C, Del Guerra S, Lupi R, Rönn T, Granhall C, Luthman H, et al. Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and Effect on insulin secretion. Diabetologia. 2008; 51: 615-22.
138. Volkmar M, Dedeurwaerder S, Cunha DA, Ndlovu MN, Defrance M, Deplus R, et al. DNA methylation profi ling identifi es epigenetic dysregulation in pancreatic islets from type 2 diabetic patients. EMBO J. 2012; 31: 1405-26.
139. Toperoff G, Aran D, Kark JD, Rosenberg M, Dubnikov T, Nissan B, et al. Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Hum Mol Genet. 2012; 21: 371-83.
140. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007; 316: 889-94.
141. Ribel-Madsen R, Fraga MF, Jacobsen S, Bork-Jensen J, Lara E, Calvanese V, et al. Genome-wide analysis of DNA methylation diff erences in muscle and fat from monozygotic twins discordant for type 2 diabetes. PLoS One. 2012; 7: e51302.
142. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature. 2001; 409: 860-921.
143. Shukla S, Kavak E, Gregory M, Imashimizu M, Shutinoski B, Kashlev M, et al. CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing. Nature. 2011; 479: 74-9.
144. Dayeh TA, Olsson AH, Volkov P, Almgren P, Rönn T, Ling C. Identifi cation of CpG-SNPs associated with type 2 diabetes and differential DNA methylation in human pancreatic islets. Diabetologia. 2013; 56: 1036-46.